Showing 168 results
-
Media Release /Early combination treatment strategy with vildagliptin and metformin was superior to standard of care in newly diagnosed type 2 diabetes patients 1,2 The landmark VERIFY study is the first to…
-
Media Release /Secukinumab is the first and only IL-17A inhibitor to show sustained improvements in signs and symptoms of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) Additional data show rapid and…
-
Media Release /Committed to reimagining medicine and discovering breakthrough treatments to improve and extend the lives of Filipinos, and increase their access to quality healthcare. Novartis is once again…
-
Media Release /Sandoz Philippines Corporation donated to the Philippine Red Cross (PRC) a year's supply of high-quality Sandoz generic medicines, which will benefit almost 1,000 patients with infections and…
-
Media Release /Themed “Creating Excellent Outcomes in the Philippine Healthcare System,” the Hospital CEO Forum 2018 is the first annual forum for CEOs of top hospitals in the Philippines. It aims to help co-…
-
Media Release /Ahead of World Leprosy Day last January 28, 2018, the Novartis Foundation joined forces with other leading leprosy groups to launch a Global Partnership for Zero Leprosy to accelerate progress…
-
Media Release /Makati City, 27 October 2018 – Sandoz Philippines and Novartis Healthcare Philippines, in partnership with the Philippine Neurological Association (PNA) and Philippine Psychiatric Association (PPA),…
-
Media Release /Community Partnership Day offers an opportunity for Novartis associates around the world to volunteer and give back to the communities in which they live and work. Novartis Healthcare Philippines…
-
Media Release /Effective July 1, 2019 the prices of six hypertension and epilepsy medicines of Novartis will be reduced substantially. The price reduction of the Novartis hypertension medicines ranges from 15% to…
-
Media Release /Heart failure (HF) is a serious, life-threatening condition that exacts a heavy socio-economic burden in the Philippines. To help enhance the quality of HF care in the country, Novartis Healthcare…
